SPYVLP01 / SpyBiotech - LARVOL DELTA

SPYVAC01: A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants (clinicaltrials.gov) - P1 | N=120 | Completed | Sponsor: SpyBiotech Limited | Active, not recruiting ➔ Completed

First-in-human • Trial completion • Cytomegalovirus Infection • Infectious Disease

Preclinical Data Supporting Development of a Novel CMV Vaccine (IDWeek 2025) - No abstract available

Preclinical • Infectious Disease

SPYVAC01: A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants (clinicaltrials.gov) - P1 | N=120 | Active, not recruiting | Sponsor: SpyBiotech Limited | Recruiting ➔ Active, not recruiting | Trial completion date: Apr 2025 ➔ Jul 2025 | Trial primary completion date: Apr 2025 ➔ Jul 2025

Enrollment closed • Trial completion date • Trial primary completion date • Cytomegalovirus Infection • Infectious Disease

SPYVAC01: A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants (clinicaltrials.gov) - P1 | N=120 | Recruiting | Sponsor: SpyBiotech Limited | Not yet recruiting ➔ Recruiting

Enrollment open • Cytomegalovirus Infection • Infectious Disease

SPYVAC01: A Phase I Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants (clinicaltrials.gov) - P1 | N=120 | Not yet recruiting | Sponsor: SpyBiotech Limited

Trial completion date • Trial initiation date • Trial primary completion date • Cytomegalovirus Infection • Infectious Disease

SPYVAC01: A Phase I Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants (clinicaltrials.gov) - P1 | N=120 | Not yet recruiting | Sponsor: SpyBiotech Limited

New P1 trial • Cytomegalovirus Infection • Infectious Disease